Nothing Special   »   [go: up one dir, main page]

CL2008000683A1 - PHARMACEUTICAL COMPOSITION INCLUDING METFORMIN R - (+) LIPOATE AND AN INHIBITOR OF THE ANGIOTENSIN CONVERSION ENZYME (ACE); UNIT DOSE FORMULATION; AND USE IN THE TREATMENT OF DIABETES. - Google Patents

PHARMACEUTICAL COMPOSITION INCLUDING METFORMIN R - (+) LIPOATE AND AN INHIBITOR OF THE ANGIOTENSIN CONVERSION ENZYME (ACE); UNIT DOSE FORMULATION; AND USE IN THE TREATMENT OF DIABETES.

Info

Publication number
CL2008000683A1
CL2008000683A1 CL200800683A CL2008000683A CL2008000683A1 CL 2008000683 A1 CL2008000683 A1 CL 2008000683A1 CL 200800683 A CL200800683 A CL 200800683A CL 2008000683 A CL2008000683 A CL 2008000683A CL 2008000683 A1 CL2008000683 A1 CL 2008000683A1
Authority
CL
Chile
Prior art keywords
lipoate
ace
diabetes
inhibitor
treatment
Prior art date
Application number
CL200800683A
Other languages
Spanish (es)
Inventor
Banavara L Vaman Rao Ma Mylari
Original Assignee
Indigene Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indigene Pharmaceuticals Inc filed Critical Indigene Pharmaceuticals Inc
Publication of CL2008000683A1 publication Critical patent/CL2008000683A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CL200800683A 2007-03-09 2008-03-07 PHARMACEUTICAL COMPOSITION INCLUDING METFORMIN R - (+) LIPOATE AND AN INHIBITOR OF THE ANGIOTENSIN CONVERSION ENZYME (ACE); UNIT DOSE FORMULATION; AND USE IN THE TREATMENT OF DIABETES. CL2008000683A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90593507P 2007-03-09 2007-03-09

Publications (1)

Publication Number Publication Date
CL2008000683A1 true CL2008000683A1 (en) 2008-08-01

Family

ID=39759819

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200800683A CL2008000683A1 (en) 2007-03-09 2008-03-07 PHARMACEUTICAL COMPOSITION INCLUDING METFORMIN R - (+) LIPOATE AND AN INHIBITOR OF THE ANGIOTENSIN CONVERSION ENZYME (ACE); UNIT DOSE FORMULATION; AND USE IN THE TREATMENT OF DIABETES.

Country Status (4)

Country Link
AR (1) AR065669A1 (en)
CL (1) CL2008000683A1 (en)
TW (1) TW200848012A (en)
WO (1) WO2008112167A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101190953B1 (en) * 2009-08-25 2012-10-12 한올바이오파마주식회사 Metformin taurine salt, preparation method thereof, pharmaceutical composition comprising the same and combination preparation comprising the same
WO2011025270A2 (en) * 2009-08-25 2011-03-03 한올바이오파마주식회사 Metformin caffeic acid salt, method for preparing same, pharmaceutical composition comprising same, and combined formulation comprising same
WO2011025267A2 (en) * 2009-08-25 2011-03-03 한올바이오파마주식회사 Metformin methanesulfonate, method for preparing same, pharmaceutical composition comprising same, and combined formulation comprising same
EP2599481A1 (en) * 2011-11-30 2013-06-05 Lunamed AG 4-phenylbutyric acid for the treatment or prevention of various diseases
EP2727587A1 (en) * 2012-10-30 2014-05-07 Pharnext Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level
EP3062782A1 (en) * 2013-10-30 2016-09-07 Pharnext Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level
EP3273965A4 (en) * 2015-03-26 2018-12-05 Merck Sharp & Dohme Corp. Composition and methods for treating chronic kidney disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6693094B2 (en) * 2001-03-22 2004-02-17 Chrono Rx Llc Biguanide and sulfonylurea formulations for the prevention and treatment of insulin resistance and type 2 diabetes mellitus
WO2003068209A1 (en) * 2002-02-14 2003-08-21 Sonus Pharmaceuticals, Inc. Metformin salts of lipophilic acids
BRPI0409136A (en) * 2003-04-09 2006-04-25 Japan Tobacco Inc pentacyclic heteroaromatic compound and medicinal use thereof
US20060154971A1 (en) * 2005-01-13 2006-07-13 Navitas Pharma Combination therapies of cicletanine and lacidipine

Also Published As

Publication number Publication date
TW200848012A (en) 2008-12-16
WO2008112167A1 (en) 2008-09-18
AR065669A1 (en) 2009-06-24

Similar Documents

Publication Publication Date Title
CL2012003026A1 (en) Pharmaceutical composition comprising pioglitazone and linagliptin; preparation procedure; Use in the treatment of type 2 diabetes or obesity.
EA201200550A1 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING BI-1356 AND METFORMIN
CL2009000967A1 (en) Compound 4-cyclobutyl-n - ((2s, 5r) -5-hydroxy-2-adamantyl) -2-morpholin-4-ylpyridine-5-carboxamide, inhibitor of the enzyme 11betahsd1; pharmaceutical composition comprising it; and its use in a method of prophylactic or therapeutic treatment of a warm-blooded animal.
CL2007003523A1 (en) COMPOUNDS DERIVED FROM HETEROCICLES REPLACED WITH MORFOLINA, INHIBITORS OF THE ACTIVITY OF PI3 QUINASA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; PHARMACEUTICAL KIT; AND ITS USE IN THE CANCER PROFILACTIC OR THERAPEUTIC TREATMENT
CL2008003116A1 (en) Bicyclic heterocyclic compounds; pharmaceutical composition comprising said compounds; and its use in the treatment or prevention of diseases such as diabetes, obesity, metabolic disorder, cardiovascular disease among others.
CL2010001361A1 (en) Compounds derived from piperidine-carboxamide, renin inhibitors; pharmaceutical composition that includes them; and use in the treatment or prevention of a circulatory disease, hypertension and / or various organic damages attributable to hypertension.
EA200802184A1 (en) PHARMACEUTICAL COMPOSITIONS WITH DPP IV INHIBITORS
BRPI0814593A2 (en) COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING AND USE OF THE COMPOUND.
CL2007003033A1 (en) COMPOUNDS DERIVED FROM BENZOILAMINO HETEROCICLOS; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT; AND USE OF THE COMPOUND IN THE TREATMENT OF TYPE II DIABETES.
BRPI0809667A2 (en) COMPOUND, MEDICINAL PRODUCT AND PHARMACEUTICAL COMPOSITION CONTAINING AND USE OF THE COMPOUND
CL2008002430A1 (en) Benzenesulfonamide derived compounds, cathepsin c inhibitors; pharmaceutical composition comprising them; and its use for the treatment of copd.
CL2008003284A1 (en) Compounds derived from 4-benzylamino-1-carboxyacyl-pyridine, cetp inhibitors; pharmaceutical composition comprising them; pharmaceutical combination; and use in the treatment of metabolic, atherosclerosis and cardiovascular diseases, among others.
CL2008000683A1 (en) PHARMACEUTICAL COMPOSITION INCLUDING METFORMIN R - (+) LIPOATE AND AN INHIBITOR OF THE ANGIOTENSIN CONVERSION ENZYME (ACE); UNIT DOSE FORMULATION; AND USE IN THE TREATMENT OF DIABETES.
CL2011000846A1 (en) Heterocyclic Substituted Compounds; pharmaceutical composition; and its use for the treatment of hepatitis c.
CL2008002049A1 (en) Macrocyclic aminoindole derived compounds; pharmaceutical composition comprising said compound; and use of the compound for the treatment of hepatitis c.
BRPI0717369A2 (en) COMPOUND, MEDICINAL PRODUCT, PHARMACEUTICAL COMPOSITION CONTAINING AND USE OF THE COMPOUND.
CL2007003643A1 (en) PHARMACEUTICAL COMPOSITION OF AZIMILIDINE THAT INCLUDES 0.5% TO APPROXIMATELY 2.5% (W / W) OF WATER; AND USE FOR THE TREATMENT OF CARDIAC ARRITMIAS.
CL2008002082A1 (en) Compounds derived from 6-phenyl-1h-imidazo [4,5-c] pyridine-4-carbonitrile, inhibitors of cathepsin s and cathepsin k; pharmaceutical composition; and use in the treatment of osteoporosis, atherosclerosis, inflammation, among other diseases.
BRPI0916571A2 (en) alkylaminomethyloxazolidinone tricyclic derivative compound, medicament and pharmaceutical composition containing it and use of the compound
CL2009001841A1 (en) Use of a sustained release composition of 4-aminopyridine to prepare a medicament useful for treating multiple sclerosis in a subject.
CL2007002769A1 (en) COMPOUNDS DERIVED FROM SULFONAMIDE; OBTAINING PROCEDURE; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DIABETES.
CL2009000665A1 (en) Pyrrolidinyl derived compounds; pharmaceutical composition comprising said compounds; and its use in the treatment of anxiety, depression or both.
BRPI0820985A2 (en) 5-Aminocyclomethyl oxazondin-2-one derivative compound, medicament and pharmaceutical composition containing them and use thereof
BRPI0720684A2 (en) compound, drug, pharmaceutical composition containing and use of compound
BRPI0913297A2 (en) composition, pharmaceutical, use of a composition, and therapeutic kit.